Organization

Indonesian Medical Education and Research Institute is lead by Board of Director and supported by experienced heads of clusters and core facilities. The Board of Directors is integrally responsible for IMERI as a medical education and research institute within the framework of FKUI

IMERI’s science activities are supported by a Scientific Advisory Board which is composed of national and international senior scientists from different fields of science, including medical, educational and related technical sciences

Groups of researchers from multiple Faculty of Medicine Universitas Indonesia (FKUI) Departments have been invited to participate in IMERI from the start and form their own cluster. These so called medical education cluster and medical research clusters include a wide range of expertise and facilities. Most of the clusters have international collaborations and are part of sustained consortia.

IMERI has three stages of organization development : (1) Organizational Establishment (2017 – 2018), (2) Organizational Enhancement (2019 – 2021), (3) Organizational Performance Acceleration (2022 – 2024). It is expected that in the near future all IMERI clusters will attain Medium-High levels on the Attractiveness and Internal Factors scales.

IMERI Organization Structure
Director: Prof. dr. Badriul Hegar, PhD, SpA (K)
Vice Director Medical Science and Innovation: Prof. Dr. dr. Budi Wiweko, SpOG (K), MPH
Vice director Medical Education: dr. Diantha Soemantri, MMedEd, PhD
Executive Secretary: Dr. dr. Trinovita Andraini, MBiomed, PhD
Coordinator Quality Assurance, Biosafety and Biosecurity: Dr. dr. Ina S. Timan, SpPK(K)
Medical Science and Innovation
Head of Clusters
Center for Sports and Exercise Studies: Dr. dr. Nani Cahyani, Sp.KO
Drug Development: Dr. Ade Arsianti, S.Si, M.Si
Human Cancer: Prof. Dr. dr. Murdani Abdullah, SpPD, KGEH
Human Genetic: Prof. dr. Damayanti R. Syarif, Ph.D, Sp.A(K)
Human Nutrition: dr. Rina Agustina, M.Sc, Ph.D
Human Reproductive, Fertility & Family Planning: Prof. Dr. dr. Andon Hestiantoro, SpOG(K) M.P.H
Infectious Disease and Immunology: Dra. Beti Ernawati Dewi, Ph.D
Medical Techonolgy: Prasandhya Astagiri Yusuf., S.Si., MT., Ph.D
Neuroscience and Brain Development: Dr. dr. Astri Budikayanti, Sp.S(K)
Occupational and Environmental Health: dr. Dewi Yunia Fitriani, Sp.OK
Stem Cell and Tissue Engineering: Prof. Dr. dr. Ismail HD, Sp.OT(K)
Head of Core Facilities
Animal Research Facilities: Dr. Dra. Puspita Eka Wuyung, M.S
Biobank: Dr. Dra. Ria Kodariah, MS
Bio-Informatics: Dr. Fadillah., S.Si., M.Si
Clinical Research Supporting Unit: Prof. dr. Franciscus D. Suyatna, Ph.D, Sp.FK
Molecular Biology and Proteomics: Prof. Dr.rer.physiol. dr. Septelia Inawati Wanandi
Head of Technology Transfer & Licensing : Dr. dr. Irma Bernadette S. Sitohang., Sp.KK (K)
Medical Education
Head of Cluster
Center of e-Learning: Desak Gede Budi K, S.Farm., Apt., M.Biomed
Indonesia Museum Health and Medicine: dr. Isabella Kurnia Liem, M. Biomed., PA., Ph.D
Knowledge Management Center: Dr. dr. Purwita Wijaya Laksmi, Sp.PD, Kger
Medical Education Center: dr. Ardi Findyartini, Ph.D
Simulation Based Medical Education Research: Dr. dr. Aida R. Tantri, Sp.A-KAR
Head Collaboration UI-UNAND-UNS : Dr. dr. Rita Mustika, M.Epid
Head of Writing Center : Dr. dr. Hariyono Winarto, SpOG (K)
Secretariat
Coodinator Building, Procurement, Asset and Information Technology: Aryo Tedjo, S.Si, M.Si
Person in Charge
Building Facilities and Maintenance: Arief Kuswandi, A.Md
Procurement of Goods and Services: Nur Sakti Pratama, SI
Asset, Equipment and Consumables Management: Darmawan, S.Gz
Building Construction Documents: Drs. Purwanto
Budgeting and Finance: Giri Meraksa, SE
Human Resources, Unit Cost & General Administration: Rifdina Afifah, S.I.K

IMERI has three stages of organization development : (1) Organizational Establishment (2017 – 2018), (2) Organizational Enhancement (2019 – 2021), (3) Organizational Performance Acceleration (2022 – 2024). It is expected that in the near future all IMERI clusters will attain Medium-High levels on the Attractiveness and Internal Factors scales.